Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Head Neck

Retrieve available abstracts of 222 articles:
HTML format

Single Articles

    December 2022
  1. PETRUZZI G, Di Giorgio D, Leone F, Pichi B, et al
    The T-shaped FST pharyngoplasty step-by-step closure technique.
    Head Neck. 2022;44:2943-2946.
    PubMed     Abstract available

  2. YIN LX, Routman DM, Day CN, Harmsen WS, et al
    Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer.
    Head Neck. 2022;44:2760-2768.
    PubMed     Abstract available

  3. MOREY T, Hodge JC, Stern C, Krishnan S, et al
    Correlation between radiologic and pathologic extranodal extension in HPV-associated oropharyngeal cancer: Systematic review.
    Head Neck. 2022;44:2875-2885.
    PubMed     Abstract available

  4. SIDDIQ S, Stephen S, Lin D, Fox H, et al
    Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus-related squamous cell cancer: Long-term results.
    Head Neck. 2022;44:2753-2759.
    PubMed     Abstract available

    November 2022
  5. BLAKE CL, Brown TE, Pelecanos A, Moroney LB, et al
    Enteral nutrition support and treatment toxicities in patients with head and neck cancer receiving definitive or adjuvant helical intensity-modulated radiotherapy with concurrent chemotherapy.
    Head Neck. 2022 Nov 25. doi: 10.1002/hed.27249.
    PubMed     Abstract available

  6. WANG Y, Zhang L, Zhang T, Jin S, et al
    Predictive effect of pretreatment nutritional risk and GLIM-defined malnutrition on the nutrition impact symptom clusters in patients with head and neck cancer undergoing radiotherapy.
    Head Neck. 2022 Nov 23. doi: 10.1002/hed.27250.
    PubMed     Abstract available

  7. LI W, Liu Q, Xu H, Wang H, et al
    Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Nov 15. doi: 10.1002/hed.27244.
    PubMed     Abstract available

  8. KOTEVSKI DP, Smee RI, Vajdic CM, Field M, et al
    Empirical comparison of routinely collected electronic health record data for head and neck cancer-specific survival in machine-learnt prognostic models.
    Head Neck. 2022 Nov 11. doi: 10.1002/hed.27241.
    PubMed     Abstract available

  9. HU X, Tian T, Zhang X, Sun Q, et al
    Neutrophil-to-lymphocyte and hypopharyngeal cancer prognosis: System review and meta-analysis.
    Head Neck. 2022 Nov 11. doi: 10.1002/hed.27246.
    PubMed     Abstract available

  10. GIANNITTO C, Mercante G, Ammirabile A, Cerri L, et al
    Radiomics-based machine learning for the diagnosis of lymph node metastases in patients with head and neck cancer: Systematic review.
    Head Neck. 2022 Nov 8. doi: 10.1002/hed.27239.
    PubMed     Abstract available

  11. YEH CF, Lee WY, Yu TH, Hsu YB, et al
    Antipsychotic drug trifluoperazine as a potential therapeutic agent against nasopharyngeal carcinoma.
    Head Neck. 2022 Nov 8. doi: 10.1002/hed.27238.
    PubMed     Abstract available

  12. GIRARDI FM, Wagner VP, Martins MD, Abentroth AL, et al
    Impact of AJCC 8 pT staging in cutaneous head and neck squamous cell carcinoma in a nonselected real-world patient sample.
    Head Neck. 2022 Nov 7. doi: 10.1002/hed.27233.
    PubMed     Abstract available

  13. DE LEO AN, Dagan R, Morris CG, Holtzman AL, et al
    Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy.
    Head Neck. 2022;44:2513-2521.
    PubMed     Abstract available

  14. MILLER JA, Moradi F, Sundaram V, Liang R, et al
    Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2491-2504.
    PubMed     Abstract available

  15. COSTANTINO A, Pace GM, Festa BM, Ferreli F, et al
    Salivary bypass tube in total laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2022;44:2608-2620.
    PubMed     Abstract available

  16. HOEBERS F, Yu E, O'Sullivan B, Postma AA, et al
    Augmenting inter-rater concordance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma: A multicenter study.
    Head Neck. 2022;44:2361-2369.
    PubMed     Abstract available

  17. BAGUE S, Leon X, Terra X, Lejeune M, et al
    Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma.
    Head Neck. 2022;44:2505-2512.
    PubMed     Abstract available

    October 2022
  18. KIM DH, Kim SW, Hwang SH
    Efficacy of optical coherence tomography in the diagnosing of oral cancerous lesion: systematic review and meta-analysis.
    Head Neck. 2022 Oct 28. doi: 10.1002/hed.27232.
    PubMed     Abstract available

  19. GALIVETI CR, Kuhnell D, Biesiada J, Zhang X, et al
    Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection.
    Head Neck. 2022 Oct 22. doi: 10.1002/hed.27231.
    PubMed     Abstract available

  20. SYKES KJ, Gibbs H, Farrokhian N, Arthur A, et al
    POINT: Pilot randomized, controlled, preoperative intervention for nutrition trial in head and neck cancer.
    Head Neck. 2022 Oct 17. doi: 10.1002/hed.27220.
    PubMed     Abstract available

  21. SANSA A, Valero C, Holgado A, Vasquez R, et al
    External validation of the H-index (host index) in patients with head and neck squamous cell carcinomas.
    Head Neck. 2022 Oct 12. doi: 10.1002/hed.27224.
    PubMed     Abstract available

  22. CHEN R, Cai Q, Lin P, Liang F, et al
    Role of immune-inflamed phenotype in the prognosis of hypopharyngeal carcinoma following primary surgery.
    Head Neck. 2022 Oct 12. doi: 10.1002/hed.27218.
    PubMed     Abstract available

  23. HE Y, Li H, Wang K, Wang J, et al
    Fourteen years old as the best age cutoff to differentiate prepubertal from pubertal papillary thyroid carcinoma.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27208.
    PubMed     Abstract available

  24. MAZUL AL, Chidambaram S, Zevallos JP, Massa ST, et al
    Disparities in head and neck cancer incidence and trends by race/ethnicity and sex.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27209.
    PubMed     Abstract available

  25. SCHLAFSTEIN AJ, Goyal S, Amini A, Karam SD, et al
    The impact of operability status on outcomes in patients with T4 larynx cancer undergoing larynx preservation.
    Head Neck. 2022 Oct 5. doi: 10.1002/hed.27204.
    PubMed     Abstract available

  26. TIRELLI G, Gardenal N, Zanelli E, Borsetto D, et al
    Prevalence and prognostic impact of retropharyngeal lymph nodes metastases in oropharyngeal squamous cell carcinoma: Meta-analysis of published literature.
    Head Neck. 2022;44:2265-2276.
    PubMed     Abstract available

  27. HADDAD G, Hueniken K, Xu MC, Bratman S, et al
    Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer.
    Head Neck. 2022;44:2181-2196.
    PubMed     Abstract available

  28. FANTINI M, Crosetti E, Pizzorni N, Sprio AE, et al
    Voice and communication after open partial horizontal laryngectomies: A cross-sectional outcome study.
    Head Neck. 2022;44:2248-2256.
    PubMed     Abstract available

    September 2022
  29. CAMPO F, Mazzola F, Bianchi G, Manciocco V, et al
    Partial laryngectomy for naive pT3N0 laryngeal cancer: Systematic review on oncological outcomes.
    Head Neck. 2022 Sep 30. doi: 10.1002/hed.27205.
    PubMed     Abstract available

  30. LIN Q, Lin S, Chen W, Chen X, et al
    Controlling Nutritional Status (CONUT) score is a prognostic marker for laryngeal cancer patients with curative resection.
    Head Neck. 2022 Sep 28. doi: 10.1002/hed.27206.
    PubMed     Abstract available

  31. BAO D, Zhao Y, Liu Z, Xu H, et al
    Magnetic resonance imaging-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Head Neck. 2022 Sep 26. doi: 10.1002/hed.27200.
    PubMed     Abstract available

  32. LEE HN, Song CM, Ji YB, Myung JK, et al
    Occult metastasis to the superficial level VI lymph nodes in papillary thyroid carcinoma.
    Head Neck. 2022 Sep 21. doi: 10.1002/hed.27191.
    PubMed     Abstract available

  33. ROJO RD, Ren JL, Lipe DN, Badr H, et al
    Neuropathic pain prevalence and risk factors in head and neck cancer survivors.
    Head Neck. 2022 Sep 21. doi: 10.1002/hed.27199.
    PubMed     Abstract available

  34. YU J, Smith J, Marwah R, Edkins O, et al
    Return to work in patients with head and neck cancer: Systematic review and meta-analysis.
    Head Neck. 2022 Sep 19. doi: 10.1002/hed.27197.
    PubMed     Abstract available

  35. BATCHELOR CJJ, Flukes SP
    Tracheostomy dependence following "organ preservation" (chemo)radiation protocol for laryngeal and hypopharyngeal cancers.
    Head Neck. 2022 Sep 19. doi: 10.1002/hed.27195.
    PubMed     Abstract available

  36. WANG Y, Yu T, Yang Z, Zhou Y, et al
    Radiomics based on magnetic resonance imaging for preoperative prediction of lymph node metastasis in head and neck cancer: Machine learning study.
    Head Neck. 2022 Sep 17. doi: 10.1002/hed.27189.
    PubMed     Abstract available

  37. WATSON LJ, Woodman SH, Ganderton D, Hutcheson KA, et al
    Development of the remote 100 ml water swallow test versus clinical assessment in patients with head and neck cancer: Do they agree?
    Head Neck. 2022 Sep 16. doi: 10.1002/hed.27194.
    PubMed     Abstract available

  38. LI R, Ye L, Zhu Y, Ding H, et al
    Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2018-2029.
    PubMed     Abstract available

  39. LI F, Hsueh C, Gong H, Zhu Y, et al
    The management of metastatic neck nodes following induction chemotherapy in N2/3 classification hypopharyngeal carcinoma.
    Head Neck. 2022;44:2009-2017.
    PubMed     Abstract available

  40. HENG Y, Xu C, Lin H, Zhu X, et al
    Recurrence risk stratification and treatment strategies of patients with stage IVa-b hypopharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2030-2039.
    PubMed     Abstract available

  41. GUO Y
    Therapy of head and neck cancer in China: Introduction to the special issue.
    Head Neck. 2022;44:2007-2008.

  42. ZHUANG B, Xiao S, Zhang L, Wang Y, et al
    Association between body composition and survival in head and neck cancer patients undergoing radiotherapy.
    Head Neck. 2022;44:2046-2054.
    PubMed     Abstract available

  43. LIU Y, Xue L, Xia Z, Zhang Q, et al
    Combined taxane, platinum, and cetuximab as a first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma: Retrospective study.
    Head Neck. 2022;44:2040-2045.
    PubMed     Abstract available

  44. FARRIS JC, Steber CR, Black PJ, Chan MD, et al
    Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures.
    Head Neck. 2022 Sep 1. doi: 10.1002/hed.27176.
    PubMed     Abstract available

    August 2022
  45. TERAZAWA K, Ohashi T, Shibata H, Ishihara T, et al
    Immune-modified Glasgow prognostic score: A new prognostic marker for head and neck cancer.
    Head Neck. 2022 Aug 23. doi: 10.1002/hed.27170.
    PubMed     Abstract available

  46. CHEN KH, Jiang YT, Zhao R, Sun YC, et al
    Development and validation of prognostic nomograms in patients with ascending type of nasopharyngeal carcinoma: A retrospective study based on SEER database.
    Head Neck. 2022 Aug 20. doi: 10.1002/hed.27172.
    PubMed     Abstract available

  47. KONUTHULA N, Do OA, Gobillot T, Rodriguez CP, et al
    Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single-institution retrospective study.
    Head Neck. 2022 Aug 5. doi: 10.1002/hed.27162.
    PubMed     Abstract available

  48. PAYNE K, Brooks J, Batis N, Taylor G, et al
    Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma.
    Head Neck. 2022 Aug 5. doi: 10.1002/hed.27167.
    PubMed     Abstract available

  49. KHAIR S, Dort JC, Quan ML, Cheung WY, et al
    Validated algorithms for identifying timing of second event of oropharyngeal squamous cell carcinoma using real-world data.
    Head Neck. 2022;44:1909-1917.
    PubMed     Abstract available

  50. MATTAVELLI D, Tomasoni M, Ferrari M, Compagnoni A, et al
    Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters.
    Head Neck. 2022;44:1857-1870.
    PubMed     Abstract available

  51. BICAKCI BC, Mustafayev TZ, Cetinayak O, Igdem S, et al
    Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007.
    Head Neck. 2022;44:1825-1832.
    PubMed     Abstract available

  52. STRAETMANS JMJAA, Stuut M, Lacko M, Hoebers F, et al
    Additional parameters to improve the prognostic value of the 8th edition of the UICC classification for human papillomavirus-related oropharyngeal tumors.
    Head Neck. 2022;44:1799-1815.
    PubMed     Abstract available

  53. ZARRABI KK, Galloway TJ, Flieder DB, Kumar SS, et al
    Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer.
    Head Neck. 2022;44:E25-E30.
    PubMed     Abstract available

  54. WEYERS BW, Birkeland AC, Marsden MA, Tam A, et al
    Intraoperative delineation of p16+ oropharyngeal carcinoma of unknown primary origin with fluorescence lifetime imaging: Preliminary report.
    Head Neck. 2022;44:1765-1776.
    PubMed     Abstract available

  55. CARPENTER DJ, Hamdi OA, Finberg AM, Daniero JJ, et al
    Laryngotracheal stenosis: Mechanistic review.
    Head Neck. 2022;44:1948-1960.
    PubMed     Abstract available

  56. BENALI J, Viljoen G, Ayad T, Gravier-Dumonceau R, et al
    Management of oral feeding following total laryngectomy around the world: YO-IFOS international study.
    Head Neck. 2022;44:1755-1764.
    PubMed     Abstract available

    July 2022
  57. DORR MC, Hoesseini A, Sewnaik A, Hardillo JA, et al
    Impact of a prognostic model for overall survival on the decision-making process in a head and neck cancer multidisciplinary consultation meeting.
    Head Neck. 2022 Jul 30. doi: 10.1002/hed.27163.
    PubMed     Abstract available

  58. BEDDOK A, Saint-Martin C, Krhili S, Eddine CA, et al
    Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure.
    Head Neck. 2022 Jul 25. doi: 10.1002/hed.27153.
    PubMed     Abstract available

  59. WANG M, Zhuoma C, Liu X, Huang Q, et al
    Loss of exosomal miR-34c-5p in cancer-associated fibroblast for the maintenance of stem-like phenotypes of laryngeal cancer cells.
    Head Neck. 2022 Jul 22. doi: 10.1002/hed.27155.
    PubMed     Abstract available

  60. MARGALIT DN, Salz T, Venchiarutti R, Milley K, et al
    Interventions for head and neck cancer survivors: Systematic review.
    Head Neck. 2022 Jul 18. doi: 10.1002/hed.27142.
    PubMed     Abstract available

  61. WILSON T, Fleischer L, Patel S, Bhatnagar A, et al
    Outcomes of curative treatment for head and neck squamous cell carcinoma in very elderly adults >/=80 years old.
    Head Neck. 2022 Jul 13. doi: 10.1002/hed.27141.
    PubMed     Abstract available

  62. KIM KN, Harton J, Mitra N, Lukens JN, et al
    Acute toxicity in patients treated with concurrent chemoradiotherapy with proton versus intensity-modulated radiation therapy for nonmetastatic head and neck cancers.
    Head Neck. 2022 Jul 13. doi: 10.1002/hed.27146.
    PubMed     Abstract available

  63. ZHOU Y, Wang J, Huang Z, Gong P, et al
    Deriving prognostic significance from a molecular subtype model of laryngeal carcinoma.
    Head Neck. 2022 Jul 9. doi: 10.1002/hed.27137.
    PubMed     Abstract available

  64. LEE MY, Lee J, Stock S, Belfiglio M, et al
    Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomy.
    Head Neck. 2022 Jul 8. doi: 10.1002/hed.27133.
    PubMed     Abstract available

  65. LEE J, Kaht D, Ali S, Johnson S, et al
    Performance of the Neck Imaging Reporting and Data System as applied by general neuroradiologists to predict recurrence of head and neck cancers.
    Head Neck. 2022 Jul 8. doi: 10.1002/hed.27138.
    PubMed     Abstract available

  66. WADHAVKAR N, Jorgensen JB, Bollig CA
    Association of comorbidity score with perioperative outcomes following transoral robotic surgery: National analysis.
    Head Neck. 2022;44:1655-1664.
    PubMed     Abstract available

  67. FROEHLICH MH, Shih MC, Shehee L, Kompelli AR, et al
    Systematic review of neuroendocrine carcinomas of the oropharynx.
    Head Neck. 2022;44:1725-1736.
    PubMed     Abstract available

  68. SWIECICKI PL, Bellile E, Casper K, Chinn SB, et al
    Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.
    Head Neck. 2022;44:1509-1519.
    PubMed     Abstract available

  69. SEO GT, Wein LE, Dowling EM, Khorsandi AS, et al
    A novel technique for management of stenosis of the postlaryngectomy stoma with preservation of a functional tracheoesophageal puncture following tracheal resection.
    Head Neck. 2022;44:1737-1741.
    PubMed     Abstract available

    Exploring the impact of metabolic imaging in head and neck cancer treatment.
    Head Neck. 2022 Jul 1. doi: 10.1002/hed.27131.
    PubMed     Abstract available

    June 2022
  71. HO CM, Chen YH, Hsu WH, Wang WY, et al
    Comparative effectiveness and stage-shift effect of endoscopic exam among newly diagnosed oral cancer patients with different stages in Taiwan.
    Head Neck. 2022 Jun 25. doi: 10.1002/hed.27123.
    PubMed     Abstract available

  72. AL-QURAYSHI Z, Sullivan CB, Allison DB, Buchakjian MR, et al
    Presentation and outcomes of patients with clinically T1-2, N0 parotid mucoepidermoid carcinoma: The roles of elective neck dissection and adjuvant radiotherapy.
    Head Neck. 2022 Jun 22. doi: 10.1002/hed.27128.
    PubMed     Abstract available

  73. DAI Y, Wang Z, Yan E, Li J, et al
    Development of a novel signature derived from single cell RNA-sequencing for preoperative prediction of lymph node metastasis in head and neck squamous cell carcinoma.
    Head Neck. 2022 Jun 21. doi: 10.1002/hed.27126.
    PubMed     Abstract available

  74. SHAO YF, Kim S, Cramer JD, Farhat D, et al
    African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27107.
    PubMed     Abstract available

  75. COSTANTINO A, Canali L, Festa BM, Spriano G, et al
    Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27121.
    PubMed     Abstract available

  76. DENISSOFF A, Huusko T, Ventela S, Niemela S, et al
    Exposure to alcohol and overall survival in head and neck cancer: A regional cohort study.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27125.
    PubMed     Abstract available

  77. YANG A, Tanamal P, Tibbetts K, Sumer B, et al
    Characteristics and outcomes of young patients with laryngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2022 Jun 16. doi: 10.1002/hed.27120.
    PubMed     Abstract available

  78. SCHAR MS, Omari TI, Woods CM, Footner LR, et al
    Pharyngeal tongue base augmentation for dysphagia therapy: A prospective case series in patients post head and neck cancer treatment.
    Head Neck. 2022 Jun 4. doi: 10.1002/hed.27104.
    PubMed     Abstract available

  79. CHARGI N, Breik O, Forouzanfar T, Martin T, et al
    Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27113.
    PubMed     Abstract available

  80. MAZZONI A, Cazzador D, Marioni G, Zanoletti E, et al
    Treatment of advanced squamous cell carcinoma of the external auditory canal: Critical analysis of persistent failures in diagnosis and surgery with a competing-risk model.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27111.
    PubMed     Abstract available

  81. ABU-SHAMA Y, Renard S, Nguyen DT, Henrot P, et al
    Descriptive analysis of recurrences of nasal intestinal-type adenocarcinomas after radiotherapy.
    Head Neck. 2022;44:1356-1367.
    PubMed     Abstract available

  82. DIERCKS GR, Rastatter JC, Kazahaya K, Kamani D, et al
    Pediatric intraoperative nerve monitoring during thyroid surgery: A review from the American Head and Neck Society Endocrine Surgery Section and the International Neural Monitoring Study Group.
    Head Neck. 2022;44:1468-1480.
    PubMed     Abstract available

  83. DE RAVIN E, Frost AS, Mady LJ, Newman JG, et al
    Transcervical styloidectomy for Eagle syndrome.
    Head Neck. 2022;44:1492-1495.
    PubMed     Abstract available

  84. TSANG RK, Chan WCP, Holsinger FC, Chung JCK, et al
    Long-term results of robotic-assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Jun 1. doi: 10.1002/hed.27115.
    PubMed     Abstract available

    May 2022
  85. KOKSAL M, Saur L, Scafa D, Sarria G, et al
    Late toxicity-related symptoms and fraction dose affect decision regret among patients receiving adjuvant radiotherapy for head and neck cancer.
    Head Neck. 2022 May 30. doi: 10.1002/hed.27103.
    PubMed     Abstract available

  86. NABUURS CH, Kievit W, Leemans CR, Smit CFGM, et al
    Evaluation of subclasses for T4-classified squamous cell carcinoma of the external auditory canal.
    Head Neck. 2022 May 13. doi: 10.1002/hed.27082.
    PubMed     Abstract available

  87. LEE J, Lee JJB, Cha IH, Park KR, et al
    Risk factor analysis of dental implants in patients with irradiated head and neck cancer.
    Head Neck. 2022 May 12. doi: 10.1002/hed.27080.
    PubMed     Abstract available

  88. DESHMUKH J, Chatterjee A, Dora TK, Bose S, et al
    Recurrence pattern with respect to two different dose fractionations in patients with locally advanced head and neck cancer treated with chemoradiation using image-guided volumetric arc therapy.
    Head Neck. 2022 May 10. doi: 10.1002/hed.27075.
    PubMed     Abstract available

  89. KUTUK T, McAllister NC, Rzepczynski AE, Williams A, et al
    Submandibular gland transfer for the prevention of radiation-induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era.
    Head Neck. 2022;44:1213-1222.
    PubMed     Abstract available

  90. PETRELLI F, Luciani A, Ghidini A, Cherri S, et al
    Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2022;44:1255-1266.
    PubMed     Abstract available

  91. MULLER RG, Weidenbecher M, Ludlow D
    PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1164-1171.
    PubMed     Abstract available

  92. STEPAN K, Craig E, Skillington SA, Deutsch BC, et al
    Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1069-1078.
    PubMed     Abstract available

  93. STEVENS MN, Gallant JN, Feldman MJ, Sermarini AJ, et al
    Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1079-1085.
    PubMed     Abstract available

    April 2022
  94. FORMAN R, Deshpande H, Burtness B, Bhatia AK, et al
    Efficacy and toxicity of weekly paclitaxel, carboplatin, and cetuximab as induction chemotherapy or in cases of metastases or relapse for head and neck cancer with a focus on elderly or frail patients.
    Head Neck. 2022 Apr 30. doi: 10.1002/hed.27077.
    PubMed     Abstract available

  95. KOBAYASHI K, Ikeda A, Matsumoto Y, Matsumura S, et al
    Surgical technique for superselective neck dissection under local anesthesia in recurrent head and neck cancer.
    Head Neck. 2022 Apr 26. doi: 10.1002/hed.27071.
    PubMed     Abstract available

  96. LI D, Li X, Fan G, Bian G, et al
    Identification of the regulatory role of the circ_0004788/miR-515-5p/FGF2 network in nasopharyngeal carcinoma development.
    Head Neck. 2022 Apr 23. doi: 10.1002/hed.27066.
    PubMed     Abstract available

  97. EARNEST-NOBLE LB, Lipsky RS, Kuhel WI, Kutler DI, et al
    Identification of occult metastatic disease via lymphoscintigraphy-guided neck dissection in N0 oral squamous cell carcinoma.
    Head Neck. 2022 Apr 16. doi: 10.1002/hed.27059.
    PubMed     Abstract available

  98. MUKHERJEE A, Wiener HW, Griffin RL, Lenneman C, et al
    Racial and rural-urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.
    Head Neck. 2022 Apr 9. doi: 10.1002/hed.27054.
    PubMed     Abstract available

  99. ZHANG W, Li L, Guo E, Zhou H, et al
    Inhibition of PDK1 enhances radiosensitivity and reverses epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 8. doi: 10.1002/hed.27053.
    PubMed     Abstract available

  100. KORPICS MC, Turchan WT, Koshy M, Spiotto MT, et al
    Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.
    Head Neck. 2022 Apr 7. doi: 10.1002/hed.27050.
    PubMed     Abstract available

  101. MAO M, Qiu K, Ren J, Zhao Y, et al
    The revised Pittsburgh staging system for middle ear squamous cell carcinoma: A challenging clinical dilemma.
    Head Neck. 2022 Apr 5. doi: 10.1002/hed.27047.

  102. JIN YN, Liu BQ, Peng KW, Ou XQ, et al
    The prognostic value of adding systemic inflammation response index to Epstein-Barr virus DNA in childhood nasopharyngeal carcinoma: A real-world study.
    Head Neck. 2022 Apr 4. doi: 10.1002/hed.27033.
    PubMed     Abstract available

  103. BIRKENBEUEL JL, Pang JC, Lee A, Nguyen ES, et al
    Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review.
    Head Neck. 2022;44:1014-1029.
    PubMed     Abstract available

  104. LEE HI, Kim JH, Lee JH, Wu HG, et al
    Reducing target volume in definitive radiotherapy for human papillomavirus-associated tonsil cancer.
    Head Neck. 2022;44:989-997.
    PubMed     Abstract available

  105. AGGARWAL P, Hutcheson KA, Goepfert RP, Garden AS, et al
    Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors.
    Head Neck. 2022;44:952-963.
    PubMed     Abstract available

  106. ADILBAY D, Valero C, Fitzgerald C, Yuan A, et al
    Outcomes in surgical management of sinonasal malignancy-A single comprehensive cancer center experience.
    Head Neck. 2022;44:933-942.
    PubMed     Abstract available

  107. YANG B, Eliot M, McClean MD, Waterboer T, et al
    DNA methylation-derived systemic inflammation indices and their association with oropharyngeal cancer risk and survival.
    Head Neck. 2022;44:904-913.
    PubMed     Abstract available

  108. WU SS, Chen B, Fleming CW, Shah AA, et al
    Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution.
    Head Neck. 2022;44:851-861.
    PubMed     Abstract available

  109. BOLLIG CA, Morris B, Stubbs VC
    Transoral robotic surgery with neck dissection versus nonsurgical treatment in stage I and II human papillomavirus-negative oropharyngeal cancer.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27045.
    PubMed     Abstract available

  110. TWU CW, Lin PJ, Tsou HH, Liu YC, et al
    Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27044.
    PubMed     Abstract available

    March 2022
  111. ARBAB M, Chen YH, Tishler RB, Gunasti L, et al
    Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.
    Head Neck. 2022 Mar 31. doi: 10.1002/hed.27031.
    PubMed     Abstract available

  112. GETZ KR, Bellile E, Zarins KR, Chinn SB, et al
    The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma.
    Head Neck. 2022 Mar 25. doi: 10.1002/hed.27040.
    PubMed     Abstract available

  113. FOLEY J, Burns CL, Ward EC, Nund RL, et al
    Post-acute health care needs of people with head and neck cancer: Mapping health care services, experiences, and the impact of rurality.
    Head Neck. 2022 Mar 23. doi: 10.1002/hed.27037.
    PubMed     Abstract available

  114. GILLEY DR, Clark AD, Wieser ME, Bollig CA, et al
    Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.
    Head Neck. 2022 Mar 22. doi: 10.1002/hed.27035.
    PubMed     Abstract available

  115. ZENGA J, Awan MJ, Frei A, Petrie E, et al
    Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model.
    Head Neck. 2022 Mar 8. doi: 10.1002/hed.27028.
    PubMed     Abstract available

  116. AL-QURAYSHI Z, Ngouajio AL, Buchakjian MR
    Presentation and outcomes of patients with clinically T1-2, N0 supraglottic squamous cell carcinoma: The role of definitive radiotherapy compared to primary partial laryngectomy.
    Head Neck. 2022;44:735-744.
    PubMed     Abstract available

  117. FENLON JB, Hutten RJ, Weil CR, Lloyd S, et al
    Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins.
    Head Neck. 2022;44:606-614.
    PubMed     Abstract available

  118. HU JQ, Yu PC, Tan LC, Wei WJ, et al
    A novel method to reconstruct right recurrent laryngeal nerve by transforming into nonrecurrent laryngeal nerve: The end-to-free vagal laryngeal branch end anastomosis.
    Head Neck. 2022;44:805-809.
    PubMed     Abstract available

    February 2022
  119. MICHMERHUIZEN NL, Ludwig ML, Birkeland AC, Nimmagadda S, et al
    Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27018.
    PubMed     Abstract available

  120. ALZAHRANI F, Sahovaler A, Mundi N, Rammal A, et al
    Transoral robotic surgery for the identification of unknown primary head and neck squamous cell carcinomas: Its effect on the wait and the weight.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27023.
    PubMed     Abstract available

  121. SCHACHTEL MJC, Gandhi M, Bowman JJ, Porceddu SV, et al
    Facial nerve perineural spread from cutaneous squamous cell carcinoma of the head and neck: A single institution analysis of epidemiology, treatment, survival outcomes, and prognostic factors.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27017.
    PubMed     Abstract available

  122. JIANG YT, Chen KH, Yang J, Liang ZG, et al
    Prognostic significance of wait time for radical radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 26. doi: 10.1002/hed.27011.
    PubMed     Abstract available

  123. JIANG YT, Chen KH, Liang ZG, Yang J, et al
    A nomogram based on tumor response to induction chemotherapy may predict survival in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 25. doi: 10.1002/hed.27020.
    PubMed     Abstract available

  124. KIM HAJ, Zeng PYF, Sorgini A, Shaikh MH, et al
    Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.
    Head Neck. 2022 Feb 21. doi: 10.1002/hed.27007.
    PubMed     Abstract available

  125. WENG JJ, Wei JZ, Li M, Ning LP, et al
    Prognostic value of hypothyroidism in patients undergoing intensity-modulated radiation therapy for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 16. doi: 10.1002/hed.27006.
    PubMed     Abstract available

  126. LIN W, Cao D, Dong A, Liang S, et al
    Systematic construction and external validation of an immune-related prognostic model for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 15. doi: 10.1002/hed.26996.
    PubMed     Abstract available

  127. NIGHTINGALE J, Gandhi M, Helena J, Bowman J, et al
    Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: Time to rethink treatment paradigms.
    Head Neck. 2022 Feb 13. doi: 10.1002/hed.27005.
    PubMed     Abstract available

  128. YANG ZC, Luo MJ, Sun XS, Liu LT, et al
    Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26999.
    PubMed     Abstract available

  129. TAKENAKA Y, Oya R, Takemoto N, Inohara H, et al
    Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26997.
    PubMed     Abstract available

  130. VANGELOV B, Bauer J, Moses D, Smee R, et al
    The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.27000.
    PubMed     Abstract available

  131. BARRETTE LX, De Ravin E, Carey RM, Mady LJ, et al
    Reconstruction following transoral robotic surgery for head and neck cancer: Systematic review.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.26998.
    PubMed     Abstract available

  132. STEPHEN SE, Murphy JM, Beyer FR, Sellstrom D, et al
    Early postoperative functional outcomes following transoral surgery for oropharyngeal cancer: A systematic review.
    Head Neck. 2022;44:530-547.
    PubMed     Abstract available

  133. DHERE VR, Escott CE, Tian S, Switchenko JM, et al
    The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures.
    Head Neck. 2022;44:382-390.
    PubMed     Abstract available

  134. SINCLAIR CF, Buczek E, Cottril E, Angelos P, et al
    Clarifying optimal outcome measures in intermittent and continuous laryngeal neuromonitoring.
    Head Neck. 2022;44:460-471.
    PubMed     Abstract available

  135. WITEK ME, Woody NM, Musunuru HB, Hill PM, et al
    Defining high-risk elective contralateral neck radiation volumes for oropharynx cancer.
    Head Neck. 2022;44:317-324.
    PubMed     Abstract available

  136. BRIL SI, Chargi N, Pezier TF, Tijink BM, et al
    Arterial calcification on preoperative computed tomography imaging as a risk factor for pharyngocutaneous fistula formation after total laryngectomy.
    Head Neck. 2022;44:307-316.
    PubMed     Abstract available

    January 2022
  137. SINGH M, Thankappan K, Balasubramanian D, Pillai V, et al
    Incorporation of adverse features in advanced oral cancer improves precision in staging and patient prognostication.
    Head Neck. 2022 Jan 31. doi: 10.1002/hed.26990.
    PubMed     Abstract available

  138. DEUNING-SMIT E, Custers JAE, Mirosevic S, Takes RP, et al
    Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors.
    Head Neck. 2022 Jan 27. doi: 10.1002/hed.26985.
    PubMed     Abstract available

  139. HOYLE JM, Correya TA, Kenzik K, Francisco L, et al
    Factors associated with loss to follow-up after radiation therapy for head and neck cancer.
    Head Neck. 2022 Jan 25. doi: 10.1002/hed.26986.
    PubMed     Abstract available

  140. LIU X, Wu B, Huang J, Qin Y, et al
    Tumor factors associated with in-field failure for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Head Neck. 2022 Jan 24. doi: 10.1002/hed.26983.
    PubMed     Abstract available

  141. TUOMI L, Dotevall H, Bergquist H, Petersson K, et al
    The effect of the Shaker head-lift exercise on swallowing function following treatment for head and neck cancer: Results from a randomized, controlled trial with videofluoroscopic evaluation.
    Head Neck. 2022 Jan 23. doi: 10.1002/hed.26982.
    PubMed     Abstract available

  142. GAO P, Peng W, Hu Y
    Prognostic and clinicopathological significance of lymphocyte-to-monocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2022 Jan 20. doi: 10.1002/hed.26952.
    PubMed     Abstract available

  143. EMERSON MA, Farquhar DR, Lenze NR, Sheth S, et al
    Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients.
    Head Neck. 2022 Jan 19. doi: 10.1002/hed.26977.
    PubMed     Abstract available

  144. MASCARELLA MA, Patel T, Vendra V, Gardiner L, et al
    Poor treatment tolerance in head and neck cancer patients with low muscle mass.
    Head Neck. 2022 Jan 12. doi: 10.1002/hed.26978.
    PubMed     Abstract available

  145. MEULEMANS J, Vanermen M, Goeleven A, Clement P, et al
    Transoral robotic surgery (TORS) using the da Vinci Xi: prospective analysis of feasibility, safety, and outcomes.
    Head Neck. 2022;44:143-157.
    PubMed     Abstract available

  146. WOISARD V, Balaguer M, Fredouille C, Farinas J, et al
    Construction of an automatic score for the evaluation of speech disorders among patients treated for a cancer of the oral cavity or the oropharynx: The Carcinologic Speech Severity Index.
    Head Neck. 2022;44:71-88.
    PubMed     Abstract available

  147. BIGELOW EO, Harris J, Fakhry C, Gillison ML, et al
    Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522.
    Head Neck. 2022;44:158-167.
    PubMed     Abstract available

  148. YANG ZC, Du CC, Liu T, Liu LT, et al
    Management of first-line palliative chemotherapy for post-treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non-gemcitabine plus cisplatin chemotherapy.
    Head Neck. 2022;44:113-121.
    PubMed     Abstract available

  149. TAN BKJ, Raghupathy J, Song HJJMD, Yeo BSY, et al
    Trainee participation does not adversely affect the safety of thyroid surgery: Systematic review and meta-analysis.
    Head Neck. 2022;44:262-274.
    PubMed     Abstract available

  150. RE M, Tomasetti M, Monaco F, Amati M, et al
    MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma.
    Head Neck. 2022;44:18-33.
    PubMed     Abstract available

    December 2021
  151. YANG L, Xue Y, Wei Z, Ren K, et al
    Local radiotherapy versus nonradiotherapy to distant lesions for metastatic nasopharyngeal carcinoma: A retrospective cohort study.
    Head Neck. 2021 Dec 27. doi: 10.1002/hed.26953.
    PubMed     Abstract available

  152. LANE C, Myers C, Jiang D, Cooke A, et al
    Selected functional outcomes in advanced oral cancer: Comparison of surgery alone versus surgery with postoperative radiotherapy.
    Head Neck. 2021 Dec 23. doi: 10.1002/hed.26968.
    PubMed     Abstract available

  153. Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 22. doi: 10.1002/hed.26947.

  154. MCCUSKER MG, Mehra R, Amr S, Taylor RJ, et al
    Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatment.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26965.
    PubMed     Abstract available

  155. LI W, Xu R, Zhu B, Wang H, et al
    Circular RNAs: Functions and mechanisms in nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26962.
    PubMed     Abstract available

  156. ROSAS RR, Nachbor KM, Handley N, Mathison G, et al
    Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26959.
    PubMed     Abstract available

  157. KIM MS, Malik NH, Chen H, Poon I, et al
    Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review.
    Head Neck. 2021 Dec 19. doi: 10.1002/hed.26948.
    PubMed     Abstract available

  158. SUN Y, Pan H, He Y, Hu C, et al
    Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26961.
    PubMed     Abstract available

  159. HAN SH, Cho D, Mohammad R, Jung YH, et al
    Use of the comprehensive geriatric assessment for the prediction of postoperative complications in elderly patients with head and neck cancer.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26958.
    PubMed     Abstract available

  160. LERE-CHEVALEYRE A, Bernadach M, Lambert C, Cassagne L, et al
    Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass.
    Head Neck. 2021 Dec 16. doi: 10.1002/hed.26954.
    PubMed     Abstract available

  161. SHEHAN JN, Alwani T, LeClair J, Mahoney TF, et al
    Social determinants of health and treatment decisions in head and neck cancer.
    Head Neck. 2021 Dec 10. doi: 10.1002/hed.26931.
    PubMed     Abstract available

  162. LIU T, Dai S, Zhang H, Zhong X, et al
    The best choice of induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma: Bayesian network meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26932.
    PubMed     Abstract available

  163. YAN F, Lao WP, Nguyen SA, Sharma AK, et al
    Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26923.
    PubMed     Abstract available

  164. JEANS EB, Shiraishi S, Manzar G, Morris LK, et al
    An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
    Head Neck. 2021 Dec 3. doi: 10.1002/hed.26937.
    PubMed     Abstract available

  165. CHOI HW, Ji YB, Kim E, Kim KN, et al
    Success rate and learning curve of intraoperative neural monitoring of the external branch of the superior laryngeal nerve in thyroidectomy.
    Head Neck. 2021;43:3946-3954.
    PubMed     Abstract available

  166. MEHTA MP, Prince R, Butt Z, Maxwell BE, et al
    Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer.
    Head Neck. 2021;43:3955-3965.
    PubMed     Abstract available

  167. RYBKIN A, Kang JJ, Lee A, Kitpanit S, et al
    The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers.
    Head Neck. 2021;43:3796-3809.
    PubMed     Abstract available

  168. BERG M, Adnan A, Hogmo A, Sjodin H, et al
    A national study of health-related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma.
    Head Neck. 2021;43:3843-3856.
    PubMed     Abstract available

  169. SOUSA LG, Lazar Neto F, Torman DK, Diaz EM, et al
    Therapeutic approaches and outcomes in patients with larynx or hypopharynx high-grade neuroendocrine carcinoma: A single-center retrospective analysis.
    Head Neck. 2021;43:3788-3795.
    PubMed     Abstract available

  170. NEWTON E, Valenzuela D, Foley J, Thamboo A, et al
    Outcomes for the treatment of locoregional recurrent nasopharyngeal cancer: Systematic review and pooled analysis.
    Head Neck. 2021;43:3979-3995.
    PubMed     Abstract available

  171. KU D, Hui M, Cheung P, Chow O, et al
    Meta-analysis on continuous nerve monitoring in thyroidectomies.
    Head Neck. 2021;43:3966-3978.
    PubMed     Abstract available

    November 2021
  172. RAVIKUMAR S, Casellas NJ, Shah S, Rieth K, et al
    Geographic disparities in head and neck cancer survival in Upstate New York 2011-2019.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26945.
    PubMed     Abstract available

  173. FENG X, Zhang T, Chou J, Liu L, et al
    Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA-seq data defines B cell immunity-related genes as a robust survival predictor.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26944.
    PubMed     Abstract available

  174. AMIN N, Maroun CA, El Asmar M, Alkhatib HH, et al
    Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26935.
    PubMed     Abstract available

  175. LI G, Xia YF, Huang YX, Okat D, et al
    Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: A cost-effectiveness analysis.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26941.
    PubMed     Abstract available

  176. CHARTERS E, Bogaardt H, Clark J, Milross C, et al
    Functional swallowing outcomes related to radiation exposure to dysphagia and aspiration-related structures in patients with head and neck cancer undergoing definitive and postoperative intensity-modulated radiotherapy.
    Head Neck. 2021 Nov 22. doi: 10.1002/hed.26936.
    PubMed     Abstract available

  177. PIAI V, Jansen F, Dahlslatt K, Verdonck-de Leeuw IM, et al
    Prevalence of neurocognitive and perceived speech deficits in patients with head and neck cancer before treatment: Associations with demographic, behavioral, and disease-related factors.
    Head Neck. 2021 Nov 19. doi: 10.1002/hed.26930.
    PubMed     Abstract available

  178. LENZE NR, Bensen JT, Farnan L, Sheth S, et al
    Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.
    Head Neck. 2021 Nov 18. doi: 10.1002/hed.26934.
    PubMed     Abstract available

  179. WU EL, Peesay T, Randall JA, Nelson LL, et al
    Increased body mass index predicts prolonged survival in patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26922.
    PubMed     Abstract available

  180. DIAO K, Wang H, Phan J
    Reply to Letter to the Editor regarding 'Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter'.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26920.

  181. WEST N, Kelly C, Kovarik J, Iqbal MS, et al
    Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26925.

  182. IOCCA O, Copelli C, Ramieri G, Zocchi J, et al
    Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis.
    Head Neck. 2021 Nov 6. doi: 10.1002/hed.26908.
    PubMed     Abstract available

  183. JING Z, Guo S, Li Y, Liang Z, et al
    FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26918.
    PubMed     Abstract available

  184. BULBUL MG, Genovese TJ, Hagan K, Rege S, et al
    Salvage surgery for recurrent squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26898.
    PubMed     Abstract available

  185. SICHERO L, Tagliabue M, Mota G, Ferreira S, et al
    Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status.
    Head Neck. 2021 Nov 2. doi: 10.1002/hed.26912.
    PubMed     Abstract available

  186. MIRZA FA, Johnson CZ, Byrd JK, Albergotti WG 3rd, et al
    Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Head Neck. 2021;43:3476-3492.
    PubMed     Abstract available

  187. FANTINI M, Crosetti E, Affaniti R, Sprio AE, et al
    Preoperative prognostic factors for functional and clinical outcomes after open partial horizontal laryngectomies.
    Head Neck. 2021;43:3459-3467.
    PubMed     Abstract available

  188. AMINI A, Morgan R, Meyer E, Fakhoury K, et al
    Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.
    Head Neck. 2021;43:3393-3403.
    PubMed     Abstract available

  189. SOLIMENO LS, Park YM, Lim JY, Koh YW, et al
    Treatment outcomes of neoadjuvant chemotherapy and transoral robotic surgery in locoregionally advanced laryngopharyngeal carcinoma.
    Head Neck. 2021;43:3429-3436.
    PubMed     Abstract available

  190. OBERSTE M, Riders A, Abbaspour B, Kerschke L, et al
    Improvement of patient stratification in human papilloma virus-associated oropharyngeal squamous cell carcinoma by defining a multivariable risk score.
    Head Neck. 2021;43:3314-3323.
    PubMed     Abstract available

  191. SMITH DH, Raslan S, Samuels MA, Iglesias T, et al
    Current salivary biomarkers for detection of human papilloma virus-induced oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:3618-3630.
    PubMed     Abstract available

  192. DAY AT, Yang AM, Tanamal P, Blackwell JM, et al
    Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2021;43:3345-3363.
    PubMed     Abstract available

  193. QUAN DL, Sukari A, Nagasaka M, Kim H, et al
    Gastrostomy tube dependence and patient-reported quality of life outcomes based on type of treatment for human papillomavirus-associated oropharyngeal cancer: Systematic review and meta-analysis.
    Head Neck. 2021;43:3681-3696.
    PubMed     Abstract available

  194. ZAKRZEWSKI M, Gannon OM, Panizza BJ, Saunders NA, et al
    Human papillomavirus infection and tumor microenvironment are associated with the microbiota in patients with oropharyngeal cancers-pilot study.
    Head Neck. 2021;43:3324-3330.
    PubMed     Abstract available

  195. ANAKAPU K, Wilson M, Findlay M, Brown T, et al
    Nutritional outcomes in patients undergoing transoral robotic surgery for head and neck cancers compared to conventional open surgery. A systematic review.
    Head Neck. 2021 Nov 1. doi: 10.1002/hed.26913.
    PubMed     Abstract available

    October 2021
  196. BRIL SI, Al-Mamgani A, Chargi N, Remeijer P, et al
    The association of pretreatment low skeletal muscle mass with chemotherapy dose-limiting toxicity in patients with head and neck cancer undergoing primary chemoradiotherapy with high-dose cisplatin.
    Head Neck. 2021 Oct 29. doi: 10.1002/hed.26919.
    PubMed     Abstract available

  197. SULTANIA M, Imaduddin M, S V Deo S, Kar M, et al
    Role of metronomic therapy for advanced oral cancers and predictors of response: A multi-institutional feasibility study.
    Head Neck. 2021 Oct 28. doi: 10.1002/hed.26904.
    PubMed     Abstract available

  198. ZHOU C, Cao H, Meng X, Zhang Q, et al
    Lnc-MEG3 inhibits invasion, migration, and epithelial- mesenchymal transition of nasopharyngeal carcinoma cells by regulating sequestosome 1.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26917.
    PubMed     Abstract available

  199. NALLANI R, Smith JB, Penn JP, Bur AM, et al
    Decision regret 3 and 6 months after treatment for head and neck cancer: An observational study of associations with clinicodemographics, anxiety, and quality of life.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26911.
    PubMed     Abstract available

  200. CHINTALA S, Quist KM, Gonzalez-DeWhitt PA, Katzenellenbogen RA, et al
    High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas.
    Head Neck. 2021 Oct 25. doi: 10.1002/hed.26906.
    PubMed     Abstract available

  201. LIU LT, Liang YJ, Guo SS, Xie Y, et al
    Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: A study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein-Barr virus DNA.
    Head Neck. 2021 Oct 12. doi: 10.1002/hed.26897.
    PubMed     Abstract available

  202. AMR S, Ioffe D, Suzuki I, Mehra R, et al
    Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 10. doi: 10.1002/hed.26893.
    PubMed     Abstract available

  203. COGNETTI DM, Johnson JM, Curry JM, Kochuparambil ST, et al
    Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 9. doi: 10.1002/hed.26885.
    PubMed     Abstract available

  204. LOU DI, Dietrich MS, Deng J, Murphy BA, et al
    Mechanisms of pain and their manifestations in head and neck cancer: Importance of classifying pain subtypes.
    Head Neck. 2021 Oct 7. doi: 10.1002/hed.26859.
    PubMed     Abstract available

  205. LARSEN MHH, Scott SI, Channir HI, Madsen AKO, et al
    Days alive and out of hospital following transoral robotic surgery: Cohort study of 262 patients with head and neck cancer.
    Head Neck. 2021 Oct 3. doi: 10.1002/hed.26880.
    PubMed     Abstract available

  206. HOLCOMB AJ, Richmon JD
    Surgical margins in a single-modality transoral robotic surgery: A conundrum-Reply.
    Head Neck. 2021;43:3219-3221.

  207. SHAH SB, Malik A
    Surgical margins in a single modality transoral robotic surgery-A conundrum.
    Head Neck. 2021;43:3217-3218.

  208. BASTERRA J, Oishi N, Lopez I, Otero M, et al
    Use of monopolar microelectrodes and radiofrequency in the treatment of arytenoid edema after partial horizontal laryngectomy and radiotherapy.
    Head Neck. 2021;43:3245-3248.
    PubMed     Abstract available

  209. WINDON MJ, Fakhry C, Margalit DN, Dey T, et al
    Epidemiologic distinctions between base of tongue and tonsil oropharyngeal carcinomas.
    Head Neck. 2021;43:3076-3085.
    PubMed     Abstract available

  210. UEHARA T, Doi H, Ishikawa K, Inada M, et al
    Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors.
    Head Neck. 2021;43:3132-3141.
    PubMed     Abstract available

  211. SHUKLA N, Ma Y, Megwalu UC
    The role of insurance status as a mediator of racial disparities in oropharyngeal cancer outcomes.
    Head Neck. 2021;43:3116-3124.
    PubMed     Abstract available

  212. SUN L, Shimunov D, Tan EX, Swisher-Mcclure S, et al
    Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery.
    Head Neck. 2021;43:3053-3061.
    PubMed     Abstract available

  213. ROWE LM, Connor NP, Russell JA
    Respiratory-swallow coordination in a rat model of chemoradiation.
    Head Neck. 2021;43:2954-2966.
    PubMed     Abstract available

  214. MENDELSOHN AH, Lawson G
    Single-port transoral robotic surgery hypopharyngectomy.
    Head Neck. 2021;43:3234-3237.
    PubMed     Abstract available

  215. GAINO F, Gorphe P, Vander Poorten V, Holsinger FC, et al
    Preoperative predictors of difficult oropharyngeal exposure for transoral robotic surgery: The Pharyngoscore.
    Head Neck. 2021;43:3010-3021.
    PubMed     Abstract available

  216. LOW CM, Balakrishnan K, Smith BM, Stokken JK, et al
    Sinonasal adenocarcinoma: Population-based analysis of demographic and socioeconomic disparities.
    Head Neck. 2021;43:2946-2953.
    PubMed     Abstract available

  217. PARHAR HS, Weinstein GS, O'Malley BW Jr, Shimunov D, et al
    Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
    Head Neck. 2021;43:2923-2934.
    PubMed     Abstract available

  218. BARBON CEA, Yao CMKL, Alvarez CP, Goepfert RP, et al
    Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis.
    Head Neck. 2021;43:2883-2895.
    PubMed     Abstract available

  219. THAKAR A, Panda S, Kakkar A, Singh V, et al
    A matched pair analysis of oncological outcomes in human papillomavirus-negative oropharyngeal squamous cell carcinoma: Transoral surgery versus radiotherapy or concurrent chemoradiation.
    Head Neck. 2021;43:2896-2906.
    PubMed     Abstract available

    September 2021
  220. SANABRIA A, Pinillos P, Lira RB, Shah JP, et al
    Current therapeutic options for low-risk papillary thyroid carcinoma: A scoping evidence review.
    Head Neck. 2021 Sep 30. doi: 10.1002/hed.26883.
    PubMed     Abstract available

  221. VILASECA I, Aviles-Jurado FX, Valduvieco I, Berenguer J, et al
    Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26878.
    PubMed     Abstract available

  222. FENG G, Wang T, Xue F, Qi Y, et al
    Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26877.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.